Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-006724)

Filing Details

Accession Number:: 0001209191-17-006724
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-01 16:38:12
Reporting Period:: 2017-01-30

Filing Date:: 2017-02-01
Accepted Time:: 2017-02-01 16:38:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1412067	Cascadian Therapeutics Inc.	CASC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242880	S Christopher Henney	C/O Cascadian Therapeutics, Inc. 2601 Fourth Ave., Suite 500 Seattle WA 98121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-01-30	25,324	$4.11	50,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average sales price per share. The shares sold at prices ranging from $3.8047 to $4.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer.